About Speid & Associates: Pharma and Biotech Regulatory Experts

We accelerate your program across the finish line competently

WHO WE ARE - -EXPERTS IN GLOBAL AND STRATEGIC REGULATORY AFFAIRS

Our deep knowledge in Regulatory Affairs allows us to make substantive contributions to your new medicine development programs. We are experts in Strategic Regulatory Affairs, Global Regulatory Affairs, and International Regulatory Affairs.

We are able to work on all therapeutic areas, and all therapeutic modalities, including orally administered drugs, injectables, inhaled therapeutics, dermatological applications, Drug-Device Combinations, and much more.

We have experience working on Rare Diseases, as well as Neglected Tropical Diseases. 

We would like to find out about your program.  We will help, or point you in the direction of those who can help if the program is not in our bailiwick.

Sometimes we are not interested in a therapeutic area. For instance, we do not work on cannabinoids, or psychedelics. These are simply not areas that interest us.  We also do not work on any type of medicine that has a reasonable potential to be addictive.

We provide expert regulatory support per week or per month. We can provide Chief Regulatory Affairs cover.  

Give us a call at 858 531 6640, or email LSPEID@SNDTM.COM. 

OUR MISSION AND COMMITMENT TO CLIENTS:

WE HELP YOU WIN YOUR DRUG DEVELOPMENT RACE

Anyone who has been trained to run will tell you that the fastest runners in a relay need to be the first and last in the line-up.  Despite this, relay racing is a team sport. Everyone on the team is important to the success of the team. 

Speid & Associates, Inc. have been in business since 2004.  Since that time we have worked on many different programs and created programs to help companies develop internal expertise.

The Drug Development Boot Camp(R) has trained hundreds of experts. You can register for the next program at www.drugstomarket.com/drugbootcamp 

We look forward to finding out how we can help you run your race the best way possible. We understand how to accelerate development programs, as well as identify potential road blocks. We are strategic, yet hands-on.

Email us now at LSPEID@SNDTM.COM

Please note: We will not reply to solicitations for your business and vendor services. 

DR LORNA SPEID: KNOWN FOR HER DECADES OF REGULATORY AFFAIRS EXPERIENCE, AND GLOBAL REGULATORY APPROVALS


Dr. Speid founded Speid & Associates in 2004 after working in three top pharma companies, and in three biotech companies.  Speid & Associates was founded to enable Dr. Speid to use her expertise to help as many companies, and therefore as many patients as possible. 

Dr. Speid’s BIO is shown below

Her full CV is available on request by emailing LSPEID@SNDTM.COM

DR LORNA SPEID’S BIO: WHY PHARMA AND BIOTECH COMPANIES CHOOSE US

Dr. Speid has secured regulatory approvals from all major regulatory authorities. 

Dr. Speid has experience with many therapeutic areas, including Oncology, Sickle Cell Disease, Influenza, Respiratory, Central Nervous System, Obesity, Diabetes, Anti-Infectives, Hormone Replacement Therapy.  

Find out more by emailing LSPEID@SNDTM.COM.  Every application she has filed to regulatory authorities has been approved.

Dr. Speid has experience conducting APPEALS, for applications that others have filed. She has a 100% track record of success with these types of challenging applications. She always says, “It is best to get it right first time”. However, if others have dug you into a hole, she will advise how to get out of it!

DR SPEID’s PAST COMPANIES  

Dr. Speid has worked for three major pharmaceutical companies. These are Sanofi in the UK (large Group Company), Ciba Geigy in Switzerland (HQ), and Novartis (HQ) in Switzerland.

She has worked for three biotechnology companies, including GeneMedicine, NewBiotics, and Avera. Dr. Speid was an officer of the last two biotechnology companies (Vice President). 

 She started Speid & Associates in 2004, and since that time has been able to work with many companies. Many of those companies have gone onto approval.